Results 131 to 140 of about 46,899 (191)

Pan-cancer multi-omic ERBB2-HER2 characterization using next-generation sequencing and quantitative proteomics. [PDF]

open access: yesNPJ Precis Oncol
Hunt AL   +12 more
europepmc   +1 more source

Selective EV Protein Sorting and Pathway Perturbation in AML Upon Synergistic FLT3 and Hedgehog Pathway Inhibition. [PDF]

open access: yesJ Extracell Vesicles
Blöchl C   +11 more
europepmc   +1 more source

Inducing TRIB2-targeted protein degradation to reverse chemoresistance in acute myeloid leukaemia. [PDF]

open access: yesBiochem J
Rigby E   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Expression of ErbB-1 and ErbB-2 in meningioma

Journal of Clinical Neuroscience, 2010
Meningiomas are benign intracranial tumours treated by neurosurgical resection. Residual or recurrent tumour may be treated with radiotherapy. Effective molecular therapy for residual and recurrent meningiomas is currently unavailable. We tested meningiomas for In-ErbB-1 and ErbB-2, and the levels were compared to normal brain, peripheral nerve ...
Agadha, Wickremesekera   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy